Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.582 USD | +2.48% | +16.88% | +8.08% |
05-09 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.08% | 118M | |
+6.94% | 111B | |
+10.81% | 106B | |
-13.08% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-10.00% | 16.81B | |
+38.67% | 12.54B | |
-24.62% | 8.09B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Wedbush Lowers Sangamo Therapeutics' Price Target to $10 From $16, Keeps Outperform Rating